Wistar Institute Appoints Ronny Drapkin as New President and CEO
The Wistar Institute has named Ronny Drapkin, a distinguished ovarian cancer researcher from the University of Pennsylvania Perelman School of Medicine, as its new president and CEO. Drapkin is set to assume his role at the end of November, succeeding Dario Altieri, the long-serving leader of the institute. Drapkin expressed his enthusiasm for the opportunity to lead a renowned research institution and foster collaborations at local, national, and international levels. He emphasized the importance of a conducive scientific environment and strong partnerships for impactful discoveries.